Rights statement: This is the Published version of the following article: Edwards M, Gallagher A, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Evans DJW. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012929. DOI: 10.1002/14651858.CD012929 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
Final published version, 208 KB, PDF document
Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License
Final published version
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma
AU - Edwards, Michaela Jane
AU - Gallagher, A.
AU - Nair, Parameswaran
AU - Drew, Stewart
AU - Vyas, Aashish
AU - Sharma, R
AU - Marsden, Paul
AU - Evans, David John William
N1 - This is the Published version of the following article: Edwards M, Gallagher A, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Evans DJW. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012929. DOI: 10.1002/14651858.CD012929 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.
PY - 2018/1/22
Y1 - 2018/1/22
N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 agents, for the treatment of children, adolescents, or adults with asthma.
AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 agents, for the treatment of children, adolescents, or adults with asthma.
U2 - 10.1002/14651858.CD012929
DO - 10.1002/14651858.CD012929
M3 - Journal article
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
SN - 1469-493X
IS - 1
ER -